Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet Luciano Artur Lopes Pereira; Catarina Meng; Manuel Augusto Gonçalves Amoedo; Maria Teresa de Sousa Costa Pinto Ferreira Mendes; Marco Alexandre Mateus Prazeres Marques; João Miguel Machado Dória Frazão; André Luiz Loureiro Weigert;

Prevalence by health areas of chronic kidney disease in the diabetic population of Extremadura in 2012, 2013 and 2014. An observational study Leandro Fernández-Fernández; Javier Goujat-Salas; Carmen Ceballos-Malagón; Manuel Tejero-Mas; Francisco Luis Pérez-Caballero; Francisco Buitrago-Ramírez;

Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease Jordi Bover; Carolt Arana; Pablo Ureña; Armando Torres; Alejandro Martín-Malo; Leonor Fayos; Verónica Coll; María Jesús Lloret; Jackson Ochoa; Yolanda Almadén; Lluis Guirado; Mariano Rodríguez;